8月1日，Core Scientific盘中下跌5.04%，报20.72美元/股，成交额1.88亿美元。消息面上，该股此前两个交易日因Keefe, Bruyette & Woods将评级重新上调至"跑赢大盘"、目标价上调至28美元而累计大幅反弹，但公司Q2每股亏损3.32美元远超市场预期的0.06至0.10美元，基本面压力尚未消化，短期获利盘回吐明显。与此同时，所属板块整体承压，AppLovin跌4.4%、IREN跌4.13%、Strategy跌4.33%，行业情绪偏弱加剧个股回调幅度。
（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。）
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.